Effects of Zoledronate on Local and Systemic Production of IL-1β, IL-18, and TNF-α in Mice and Augmentation by Lipopolysaccharide-Reference-Cited by-同舟云学术

Effects of Zoledronate on Local and Systemic Production of IL-1β, IL-18, and TNF-α in Mice and Augmentation by Lipopolysaccharide

Published:2019-06-01 Issue:6 Volume:42 Page:929-936
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Funayama Hiromi¹,Tashima Itaru¹,Okada Satoru²,Ogawa Takuya³,Yagi Hideki⁴,Tada Hiroyuki⁵,Wakita Ryo⁶,Asada Yoshinobu¹,Endo Yasuo²

Affiliation:

1. Department of Pediatric Dentistry, Tsurumi University School of Dental Medicine

2. Division of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Tohoku University

3. Division of Cell Biology, Department of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare

4. Division of Immunobiology, Department of Pharmaceutical Sciences, School of Pharmacy, International University of Health and Welfare

5. Division of Oral Molecular Regulation, Graduate School of Dentistry, Tohoku University

6. Section of Anesthesiology and Clinical Physiology, Department of Oral Restitution, Division of Oral Health Sciences, Graduate School, Tokyo Medical and Dental University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/6/42_b18-00923/_pdf

Reference53 articles.

1. 1) Roelofs AJ, Thompson K, Gordon S, Rogers MJ. Molecular mechanisms of action of bisphosphonates: current status. Clin. Cancer Res., 12, 6222s–6230s (2006).

2. 2) Adami S, Zamberlan N. Adverse effects of bisphosphonates. A comparative review. Drug Saf., 14, 158–170 (1996).

3. 3) Ruggiero SL. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development. J. Oral Maxillofac. Surg., 67 (Suppl.), 13–18 (2009).

4. 4) Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann. Intern. Med., 144, 753–761 (2006).

5. 5) Yamaguchi K, Oizumi T, Funayama H, Kawamura H, Sugawara S, Endo Y. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale. J. Oral Maxillofac. Surg., 68, 889–897 (2010).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate;Scientific Reports;2024-01-05

2. Alendronate reduces periosteal microperfusion in vivo;Heliyon;2023-09

3. Atorvastatin reduces zoledronic acid-induced osteonecrosis of the jaws of rats;Bone;2022-11

4. Histamine acts via H4-receptor stimulation to cause augmented inflammation when lipopolysaccharide is co-administered with a nitrogen-containing bisphosphonate;Inflammation Research;2022-10-29

5. Nitrogen‐containing bisphosphonates and lipopolysaccharide mutually augment inflammation via adenosine triphosphate (ATP)‐mediated and interleukin 1β (IL‐1β)‐mediated production of neutrophil extracellular traps (NETs);Journal of Bone and Mineral Research;2021-06-22